Minimal Residual Disease and Circulating Tumor Cells in Breast Cancer

1. Minimal Residual Disease and Circulating Tumor Cells in Breast Cancer: Open Questions for Research
Michail Ignatiadis, Christos Sotiriou, Klaus Pantel

2. Self-Seeding in Cancer
Elizabeth Comen, Larry Norton

3. Microenvironments Dictating Tumor Cell Dormancy
Paloma Bragado, Maria Soledad Sosa, Patricia Keely, John Condeelis, Julio A. Aguirre-Ghiso

4. Immunomagnetic Separation Technologies
Astrid E. L. M. Hoeppener, Joost F. Swennenhuis, Leon W. M. M. Terstappen

5. Microfluidic Technologies
Ali Asgar. S. Bhagat, Chwee Teck Lim

6. EPISPOT Assay: Detection of Viable DTCs/CTCs in Solid Tumor Patients
Catherine Alix-Panabières

7. Advances in Optical Technologies for Rare Cell Detection and Characterization
Lou Dietz, Richard Bruce

8. Size-Based Enrichment Technologies for CTC Detection and Characterization
Anthony Williams, Marija Balic, Ram Datar, Richard Cote

9. Emerging Technologies for CTC Detection Based on Depletion of Normal Cells
Maryam Lustberg, Kris R. Jatana, Maciej Zborowski, Jeffrey J. Chalmers

10. Molecular Assays for the Detection and Characterization of CTCs
Evi S. Lianidou, Athina Markou

11. Multiplex Molecular Analysis of CTCs
Anieta M. Sieuwerts, Stefanie S. Jeffrey

12. Circulating DNA and Next-Generation Sequencing
Susanna Cooke, Peter Campbell

13. Circulating MicroRNAs as Noninvasive Biomarkers in Breast Cancer
Maria Angelica Cortez, James William Welsh, George Adrian Calin

14. Circulating Endothelial Cells and Circulating Endothelial Progenitors
Patrizia Mancuso, Angelica Calleri, Francesco Bertolini

15. DTCs in Breast Cancer: Clinical Research and Practice
W. Janni, Brigitte Rack, N. Kasprowicz, C. Scholz, P. Hepp

16. CTCs in Primary Breast Cancer (I)
Brigitte Rack, Ulrich Andergassen, Wolfgang Janni, Julia Neugebauer

17. CTCs in Primary Breast Cancer (II)
E. Saloustros, D. Mavroudis

18. CTCs in Metastatic Breast Cancer
Antonio Giordano, Massimo Cristofanilli

19. HER2-Positive DTCs/CTCs in Breast Cancer
Andreas D. Hartkopf, Malgorzata Banys, Tanja Fehm

20. DTCs/CTCs in Breast Cancer: Five Decades Later
Susan Alsamarai, Maysa M. Abu-Khalaf, Lyndsay N. Harris

21. Challenges in Drug and Biomarker Co-Development
Sheila E. Taube, Tracy Lively

22. Challenges and Opportunities in the Use of CTCs for Companion Diagnostic Development
Elizabeth A. Punnoose, Mark R. Lackner

Avainsanat: Medicine & Public Health, Oncology, Gynecology, Surgical Oncology, Pathology, Cancer Research